Literature DB >> 22035874

Low surface contamination by cis/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC).

R Schierl1, J Novotna, P Piso, A Böhlandt, D Nowak.   

Abstract

AIM: The aim of this study was to evaluate contamination by platinum drugs in the operating room during hyperthermic intraperitoneal chemotherapy (HIPEC).
METHODS: Environmental sampling of 151 wipe samples from surfaces on the HIPEC devices and operating room floors was performed for platinum in six German hospitals during 19 HIPEC procedures. Additionally, 45 wipe samples from surgeons' and perfusionists' protective gloves were analyzed.
RESULTS: Platinum concentrations from the HIPEC devices and operating room floors ranged from 0.07 to 110,000 pg/cm(2) (Median: 1.5 pg/cm(2)) with high contamination on the regulation knob and reservoir after HIPEC procedure, particularly when injecting the cytostatic drug into the reservoir via syringe. Samples from perfusionists' and surgeons' protective gloves ranged between 0.01 and 729 ng/pair.
CONCLUSIONS: Although sporadically high platinum concentrations on surfaces on the HIPEC device and operating room floor were detected, our study revealed that low surface loads are definitely possible and can be documented by wipe samples. Important factors for achieving low surface contamination are the use of infusion bags instead of syringes for injection of the cytostatic solution, careful cleaning of the device after HIPEC and wearing of two pairs of gloves.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22035874     DOI: 10.1016/j.ejso.2011.10.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  12 in total

1.  Establishing of Peritoneal Surface Malignancy Treatment Program: Background in Ukraine, Patient Selection, Staff Schedule, Perioperative Outcomes of First 28 Patients.

Authors:  V I Kopetskyi; K V Kopchak; D O Cheverdiuk; O O Kvasivka; A P Beznosenko; O O Kolesnik; V V Gushchin
Journal:  Indian J Surg Oncol       Date:  2020-03-16

Review 2.  Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.

Authors:  Ramez N Eskander; James Cripe; Robert E Bristow
Journal:  Curr Treat Options Oncol       Date:  2014-03

Review 3.  Safety considerations for Health care Workers involved in Cytoreductive Surgery and Perioperative chemotherapy.

Authors:  Aditi Bhatt; Sourabh Mittal; K S Gopinath
Journal:  Indian J Surg Oncol       Date:  2016-02-02

4.  From a Chemotherapeutic Drug to a High-Performance Nanocatalyst: A Fast Colorimetric Test for Cisplatin Detection at ppb Level.

Authors:  Valentina Mastronardi; Mauro Moglianetti; Edoardo Ragusa; Rodolfo Zunino; Pier Paolo Pompa
Journal:  Biosensors (Basel)       Date:  2022-05-30

5.  Cisplatin and oxaliplatin surface contamination in intensive care units (ICUs) and hospital wards during attendance of HIPEC patients.

Authors:  K-E Schenk; R Schierl; M Angele; A Burkhart-Reichl; G Glockzin; A Novotny; D Nowak
Journal:  Int Arch Occup Environ Health       Date:  2016-05-03       Impact factor: 3.015

6.  Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC).

Authors:  Antoine F Villa; Souleiman El Balkhi; Radia Aboura; Herve Sageot; Helene Hasni-Pichard; Marc Pocard; Dominique Elias; Nathalie Joly; Didier Payen; François Blot; Joel Poupon; Robert Garnier
Journal:  Ind Health       Date:  2014-10-17       Impact factor: 2.179

Review 7.  Identification of Knowledge Gaps Regarding Healthcare Workers' Exposure to Antineoplastic Drugs: Review of Literature, North America versus Europe.

Authors:  Chun-Yip Hon; Cris Barzan; George Astrakianakis
Journal:  Saf Health Work       Date:  2014-06-11

8.  Consensus statement on safety measures for pressurized intraperitoneal aerosol chemotherapy.

Authors:  Arnaud Girardot-Miglierina; Daniel Clerc; Mohammad Alyami; Laurent Villeneuve; Olivia Sgarbura; Marc-André Reymond; Martin Hübner
Journal:  Pleura Peritoneum       Date:  2021-11-02

9.  Exposure to cisplatin in the operating room during hyperthermic intrathoracic chemotherapy.

Authors:  Till Markowiak; Michael Ried; Christopher Larisch; Dennis Nowak; Hans-Stefan Hofmann; Stefan Rakete
Journal:  Int Arch Occup Environ Health       Date:  2021-06-30       Impact factor: 3.015

10.  Current practice and perceptions of safety protocols for the use of intraperitoneal chemotherapy in the operating room: results of the IP-OR international survey.

Authors:  Daniel Clerc; Martin Hübner; K R Ashwin; S P Somashekhar; Beate Rau; Wim Ceelen; Wouter Willaert; Naoual Bakrin; Nathalie Laplace; Mohammed Al Hosni; Edgar Luis Garcia Lozcano; Sebastian Blaj; Pompiliu Piso; Andrea Di Giorgio; Giuseppe Vizzelli; Cécile Brigand; Jean-Baptiste Delhorme; Amandine Klipfel; Rami Archid; Giorgi Nadiradze; Marc A Reymond; Olivia Sgarbura
Journal:  Pleura Peritoneum       Date:  2021-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.